Drug Shortage Report for VISIPAQUE 270
Report ID | 227151 |
Drug Identification Number | 02145766 |
Brand name | VISIPAQUE 270 |
Common or Proper name | iodixanol injection USP |
Company Name | GE HEALTHCARE CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | IODIXANOL |
Strength(s) | 550MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRA-ARTERIAL INTRA-ARTERIAL INTRAVENOUS |
Packaging size | 100 mL |
ATC code | V08AB |
ATC description | X-RAY CONTRAST MEDIA, IODINATED |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2024-05-08 |
Actual start date | 2024-05-10 |
Estimated end date | 2024-05-21 |
Actual end date | 2024-05-17 |
Shortage status | Resolved |
Updated date | 2024-05-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
Company contact information | 800-387-7146 canadainfo@gehealthcare.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2024-05-18 | English | Compare |
v10 | 2024-05-17 | French | Compare |
v9 | 2024-05-17 | English | Compare |
v8 | 2024-05-11 | English | Compare |
v7 | 2024-05-10 | French | Compare |
v6 | 2024-05-10 | English | Compare |
v5 | 2024-05-10 | French | Compare |
v4 | 2024-05-10 | English | Compare |
v3 | 2024-05-09 | English | Compare |
v2 | 2024-05-06 | French | Compare |
v1 | 2024-05-06 | English | Compare |
Showing 1 to 11 of 11